Manoj Chelvanambi

Jul 12, 2023 | cell.com | Manoj Chelvanambi |Jennifer Wargo

• None Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. :• None Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. :• None Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer. :• None Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.